Concepedia

Publication | Open Access

Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial

DOIFull Paper Access

228

Citations

12

References

2014

Year

Bruce A. Perkins, David Z.I. Cherney, Helen Partridge, Nima Soleymanlou, Holly Tschirhart, Bernard Zinman, Nora Fagan, Stefan Kaspers, Hans‐Juergen Woerle, Uli C. Broedl,
Diabetes Care

Abstract

This proof-of-concept study strongly supports a randomized clinical trial of adjunctive-to-insulin empagliflozin in patients with T1D.

References

YearCitations

Page 1